ArticleEuropean journal of immunology2020

High-throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells.

Paul Tuijnenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.